Home › Neuroendocrine Tumors › Virginia › Charlottesville
Neuroendocrine Tumors clinical trials in Charlottesville, VA
6 studies for Neuroendocrine Tumors are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- University of Virginia, Charlottesville
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RecruitingPhase 3
- University of Virginia Comprehensive Cancer Center, Charlottesville
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Charlottesville
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Virginia Cancer Center, Charlottesville
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Charlottesville
Neuroendocrine Tumors trials in other cities
- Philadelphia, PA11 studies
- Washington, DC11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- Columbus, OH7 studies
- Chicago, IL7 studies
- St. Louis, MO7 studies
- Salt Lake City, UT7 studies
- Cleveland, OH7 studies
- Detroit, MI7 studies
- Dallas, TX6 studies
- Lexington, KY6 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia16 studies
- Prostate Cancer15 studies
- Cancer (all types)13 studies
- Endometrial Cancer13 studies
- Metastatic Cancer13 studies
- Lung Cancer13 studies
- Heart Failure12 studies
- Colorectal Cancer10 studies
- Ovarian Cancer10 studies
- Type 1 Diabetes9 studies
- Breast Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.